We sell the original Can-C eye-drop used in the clinical trials by IVP and Dr. Mark Babizhayev. IVP maintains that only the original unadulterated formula is effective in reducing, reversing and slowing the occurrence of senile cataract.
Can-C has been proven to reduce the occurrence and slow the development of senile cataract.
Can-C can assist to lower the intraocular pressure associated with glaucoma.
Can-C is also beneficial for contact lens disorders.
Can-C has been shown to help those suffering from presbyopia.
Can-C can be used to treat corneal disorders.
Can-C can combat eyestrain.
Can-C can ease computer vision syndrome.
Can-C can end the discomfort of ocular inflammation.
Can-C can restore normal sight to those inflicted with blurred vision.
Can-C can alleviate dry eye syndrome.
Can-C has been used with great success in the fight against retinal diseases.
Can-C has been used in the treatment of vitreous opacities and lesions.
Can-C has a wealth of properties which can improve the function of the aging eye.
All information is reproduced with the kind permission of IAS. Copyright IAS.
